Avectas — Solupore® Integrated
Resources

Publications, application notes and technical documentation.

Explore the science behind Solupore® Integrated. Contact Avectas to discuss specific requirements or request full documents.

Publication

Thermo Fisher Scientific Collaboration

First study to successfully demonstrate reprogramming of blood cell types using srRNA to produce functional iPSCs.

Request document
Poster

Avectas ISCT Poster 2025

A scalable, rapid & automated manufacturing platform, Solupore® Integrated, for autologous and allogeneic cell therapies.

Request document
Application note

Avectas + Sony Application Note

Solupore® Integrated transfected cells isolated using Sony's CGX10 yield highly cytotoxic CAR-T cells.

Request document
Publication

Avectas — Molecular Therapy

Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system.

Request document
Application note

Avectas × ScaleReady — App Note 3

Enhanced Stem Cell Memory and Cytotoxic Function in Engineered T Cells Expanded for 7 days to >1.3×10⁹.

Request document
Application note

Avectas × ScaleReady — App Note 2

Solupore® Integrated Triple Knock-Out Transfected T-cell Expansion Equivalent to Untransfected in G-Rex Platform.

Request document
Application note

Avectas × ScaleReady — App Note 1

Solupore® Integrated Triple Knock-Out Transfected T-cell Expansion Equivalent to Untransfected in G-Rex® Platform.

Request document
Publication

Avectas — Cytotherapy

Novel non-viral delivery method enabling efficient engineering of primary human T cells for ex vivo cell therapy applications.

Request document
Publication

Avectas — PLOS One

Vector-free intracellular delivery by reversible permeabilization.

Request document
Whitepaper

Avectas Whitepaper

Automated, reproducible transfection system for delivery of RNA, DNA and protein to primary immune cells used in clinical cell therapy.

Request document
Brochure

Non-viral delivery platform for cell engineering

How Solupore® Integrated accelerates the future of cell therapies through healthier and more functional cells.

Request document
Application note

Avectas × Lumicks — App Note

Solupore® Integrated demonstrates superior cellular avidity, essential for optimising cell therapy processes.

Request document
Application note

Avectas × GenScript — App Note

Solupore® Integrated knock-in using GenScript GenExact™ single-stranded DNA.

Request document
Application note

Activation-Free Transfection App Note

Activation-Free Transfection with Solupore® Integrated: Preserving Naïve T-cell Phenotypes.

Request document
Contact